Suppr超能文献

将秋水仙碱用于治疗心脏病(药物用途拓展)

Repurposing Colchicine for Heart Disease.

作者信息

Bouabdallaoui Nadia, Tardif Jean-Claude

机构信息

Montreal Heart Institute, Montreal, Quebec H1T 1C8, Canada; email:

Faculty of Medicine, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.

出版信息

Annu Rev Pharmacol Toxicol. 2022 Jan 6;62:121-129. doi: 10.1146/annurev-pharmtox-052120-020445. Epub 2021 Sep 30.

Abstract

Colchicine is one of the most ancient medications still prescribed. It is extracted from the plant and is routinely used because of its broad anti-inflammatory properties to treat gout and familial Mediterranean fever. Colchicine has shown efficacy in various clinical settings in which inflammation is a key component, and it has become first-line therapy for acute and recurrent pericarditis. Two landmark clinical trials have recently shown that colchicine significantly improves cardiovascular outcomes on background statin and antiplatelet therapy in patients with coronary artery disease, supporting its role for the prevention of atherothrombotic events. Favorable results have also emerged in atrial fibrillation. We herein briefly review the most recent data related to the multiple cardiovascular conditions for which colchicine has been successfully repurposed.

摘要

秋水仙碱是仍在使用的最古老药物之一。它从植物中提取,因其广泛的抗炎特性而被常规用于治疗痛风和家族性地中海热。秋水仙碱在炎症是关键因素的各种临床环境中已显示出疗效,并且已成为急性和复发性心包炎的一线治疗方法。最近两项具有里程碑意义的临床试验表明,在接受他汀类药物和抗血小板治疗的冠心病患者中,秋水仙碱可显著改善心血管预后,这支持了其在预防动脉粥样血栓形成事件中的作用。在心房颤动方面也出现了有利结果。我们在此简要回顾与秋水仙碱已成功用于多种心血管疾病相关的最新数据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验